Should You Buy Nature's Ledger Before the SPAC Merger Closes?
Nature's Ledger is a carbon credits and natural-asset tokenization platform going public through a merger with Globa Terra Acquisition Corp (GTERA). The deal implies a $323.8 million pre-money valuation, but the setup still hinges on redemptions, PIPE execution, and whether the company can convert its niche model into real public-market scale.
Nature's Ledger is a carbon credits and natural-asset tokenization platform going public through a merger with Globa Terra Acquisition Corp (GTERA). The deal implies a $323.8 million pre-money valuation, but the setup still hinges on redemptions, PIPE execution, and whether the company can convert its niche model into real public-market scale.
Deal at a Glance
SPAC partner: Globa Terra Acquisition Corp
SPAC ticker (trades now): GTERA
Implied valuation: $323.8M pre-money equity value
Expected close: late 2026 to early 2027
Est. first trading date: late 2026 to early 2027
Deal status: Announced
Source filing: SEC EX-99.1 (2026-11-10)
Company Overview
Nature's Ledger describes itself as an integrated real-world asset platform that sources, structures, and tokenizes nature-based assets for capital markets. On its website, it says those assets include agriculture, biodiversity, carbon, soil, and water, and that it uses long-term land agreements, validation frameworks, and digital infrastructure to connect physical assets to investors. The company also says it is Canada’s first vertically integrated natural asset tokenization ecosystem.
The deal press release gives a more traditional operating description: Nature's Ledger focuses on the origination, development, verification, aggregation, registration, and commercialization of carbon credits and environmental attributes, plus related advisory and MRV services. The company says it has a pipeline spanning natural assets, physical infrastructure, First Nations projects, and commodities, with Carbon RX handling carbon-credit project development and marketplace activity. It does not disclose a founding year, headquarters address, employee count, or operating KPIs on the pages reviewed.
Industry-wise, Nature's Ledger is positioning itself in a fragmented carbon markets and environmental-attributes space. The opportunity is real, but the public comp set is thin because the business mixes project development, environmental-market services, and tokenization infrastructure rather than fitting neatly into one listed category.
The SPAC Deal
Nature's Ledger is merging with Globa Terra Acquisition Corp, which trades today under the ticker GTERA. The press release says the transaction implies an indicated Nature's Ledger pre-money equity value of approximately $323.8 million, subject to adjustments in the merger agreement. That is the only valuation figure disclosed in the sources reviewed so far.
The trust account is the key swing factor. Globa Terra's June 30, 2026 10-Q shows $181,488,610 in cash held in trust, based on 17,499,550 Class A shares subject to possible redemption at $10.37 per share. Redemption risk is material: the proxy says holders can redeem in connection with the extension vote, and the amount remaining in trust after redemptions may be only a small fraction of the amount then in trust. The deal also includes a proposed PIPE financing, but the size, investors, and terms were not disclosed, so shareholders should watch for whether that capital actually lands and how much dilution it brings.
The sponsor and warrant stack also matters. The proxy discloses 17,499,550 IPO units, 394,267 private placement units, 788,534 restricted Class A shares, and warrants exercisable 30 days after the initial business combination at $11.50 per share. The sponsor may also provide up to $2.5 million of working-capital loans, some of which may convert into private units at $10.00 per unit. The transaction is announced but not closed, and the company said it intends to file an F-4 or S-4 registration statement and proxy/prospectus materials. Based on the extension proposal moving the deadline from October 9, 2026 to July 9, 2027, the estimated first-trading window is late 2026 to early 2027 if the merger clears the vote and closes on a normal SPAC timeline. The expected post-merger ticker was not disclosed in the available materials.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
The SPAC route gives Nature's Ledger a faster path to public capital than a traditional IPO and lets it present a growth story around carbon credits, environmental attributes, and tokenized natural assets while the market is still forming. The company also appears to be using the merger to fund expansion across project origination, verification, aggregation, registration, commercialization, and related advisory/MRV services.
A de-SPAC can also be useful for a business like this because it can lean on projections and a longer-form strategic narrative in the merger proxy, which is often harder to frame in a standard IPO process. The tradeoff is that the market will scrutinize the trust balance, any PIPE, and the dilution stack much more closely than it would in a normal listing.
Financial Highlights
Nature's Ledger's own revenue, losses, cash, and projections were not disclosed in the press release or website pages reviewed. That means investors do not yet have the core operating numbers they would normally use to judge whether the company can justify a $323.8 million pre-money valuation. The key financial disclosures should appear in the forthcoming F-4/S-4 proxy/prospectus.
For Globa Terra, the SPAC shell itself is small relative to the deal. The June 30, 2026 10-Q shows cash of $267,658, cash held in trust of $181,488,610, total assets of $181,872,782, total liabilities of $1,316,814, and shareholders' deficit of $(932,642). For the six months ended June 30, 2026, it reported formation and operating expenses of $413,196, offset by income earned on cash held in trust of $3,107,657, resulting in net income of $2,694,461. That is trust income, not operating revenue.
Risk Factors
The biggest de-SPAC risk is redemption. If a large number of Globa Terra shareholders redeem, the cash available at closing can shrink quickly, which can force the company to lean harder on PIPE money, backstop capital, or a smaller transaction. The proxy explicitly warns that the amount left in trust after redemptions may be only a small fraction of the amount then in trust.
The second layer is dilution and execution risk. The sponsor promote, private placement units, and public warrants all sit ahead of common shareholders in the capital structure, and the warrants become exercisable at $11.50 per share after closing. The deal also still needs to close, the PIPE may not materialize or may come in smaller than expected, and the combined company may face Nasdaq listing risk if it cannot satisfy exchange requirements. On top of that, Nature's Ledger is exposed to competition, regulatory approvals, and execution risk in carbon markets and environmental attributes, where commercial adoption can be uneven and project timelines can slip.
Comparable Public Companies
The closest public comps are imperfect, but the market usually looks to adjacent carbon and environmental-asset names. Carbon Streaming Corp. (NETZ) is the most direct listed peer in terms of carbon-credit exposure, though the business model is not identical. KRBN is not an operating company, but it is a liquid market proxy for carbon pricing exposure, and CRBN is a broader low-carbon market proxy rather than a direct comp.
The broader comp set is thin because many of the closest business models are private. Xpansiv-related market infrastructure and South Pole are relevant analogs, but not public tickers. That means there is no clean, source-backed trading multiple range to anchor this deal to, and investors should treat the comp set as directional rather than definitive. The public names cited in the available materials are NETZ, KRBN, and CRBN, with the rest of the ecosystem largely private.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
This is a story-stock de-SPAC with a real thematic angle, but the setup still depends on the mechanics. The headline number is the $323.8 million pre-money valuation, yet the more important question is how much of the $181.5 million trust survives redemptions and whether the proposed PIPE actually shows up. Until the F-4/S-4 lands, shareholders are still missing the most important pieces: pro forma ownership, full financing terms, and the post-close ticker.
What shareholders should watch now is simple: redemption levels, PIPE disclosure, and the merger vote timeline. If the deal closes with decent trust retention and real outside capital, Nature's Ledger gets a cleaner runway into public markets. If redemptions are heavy or financing comes in light, the dilution burden rises fast and the public float may not reflect the headline valuation. That is why this matters now: the company is trying to list into a niche market with a big narrative, but the de-SPAC structure will decide how much of that narrative survives into the stock.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
